- Dupilumab, sold
under the
brand name
Dupixent, is a
monoclonal antibody blocking interleukin 4 and
interleukin 13, used for
allergic diseases such as atopic...
-
lonafarnib capsule". dailymed.nlm.nih.gov.
Retrieved 2021-07-01. "DailyMed -
DUPIXENT-
dupilumab injection, solution". dailymed.nlm.nih.gov.
Retrieved 2021-07-01...
- (Ranolazine), for
stable angina,
marketed by
Gilead Sciences. –
Dermatology Dupixent (Dupilumab), for eczema,
marketed by Regeneron.
Dynabac (Dirithromycin)...
- 1016/S1470-2045(15)00132-1. PMID 26179200. https://www.regeneron.com/sites/default/files/
Dupixent_FPI.pdf[bare URL PDF] http://www.pieris.com/pipeline/respiratory-anemi...
- the FDA in July 2015, It is
reported to cost $4,500 to $8,000 per year.
Dupixent (dupilumab injection) is for the
treatment of
adolescent and
adult patients'...
- have been do****ented in
literature include Tacrolimus, Pimecrolimus, and
Dupixent. Some
physicians have also seen
positive outcomes with oral Doxycycline...
- BioNTech)
GlaxoSmithKline Amoxil (amoxicillin),
Ventolin (salbutamol)
Sanofi Dupixent (dupilumab, co-op with
Regeneron Pharmaceutical),
Lantus (insulin glargine)...
- Bayh–Dole Act.
Aldurazyme Alprolix Aubagio Cablivi Cerdelga Cerezyme Clolar Dupixent Elitek Eloctate Eloxatin Fabrazyme Jevtana Kevzara Lemtrada Libtayo Lumizyme...
- and
belongs to the
chemical class of
purine analogues.[citation needed]
Dupixent was the
first medication approved by the FDA in
September 2022 to treat...
-
increase the risk of conjunctivitis.
Among monoclonal antibodies,
dupilumab (
Dupixent) and
tralokinumab (Adtralza, Adbry) are
approved to
treat moderate-to-severe...
